Wolverine Asset Management LLC Aerie Pharmaceuticals Inc Put Options Transaction History

Wolverine Asset Management LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 04, 2022	SELL	$5.64 - $9.8 $11,280 - $19,600	-2,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$11.32 - $16.63 $22,640 - $33,260	2,000 New	2,000 $22,000
Q3 2020 Nov 13, 2020	SELL	$10.46 - $14.46 $163,176 - $225,576	-15,600 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$12.0 - $16.13 $30,000 - $40,325	-2,500 Reduced 13.81%	15,600 $230,000
Q1 2020 May 13, 2020	BUY	$11.84 - $25.52 $184,704 - $398,112	15,600 Added 624.0%	18,100 $244,000
Q4 2019 Feb 14, 2020	BUY	$17.72 - $25.1 $44,300 - $62,750	2,500 New	2,500 $60,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.